NCT05498870

iPACK for Post-op Pain Following ACL Reconstruction

Studying the Effects of iPACK Blocks With Adductor Canal Blocks for Postoperative Analgesia Following ACL Reconstruction

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 82 (actual)
• Sponsor: Medical University of South Carolina · Academic / Other
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

This study will consist of patients 12 years and older undergoing ACL reconstruction using a quadriceps or bone-patella tendon bone (BTB) graft. The patients will be randomized to adductor canal block alone, or adductor canal block + iPACK block. The primary goal will be to determine the differences in postoperative pain during the first 72 hours when comparing the two groups. Secondary outcomes will include opioid utilization during the first 72 hours postoperatively and range of motion including terminal knee extension at postoperative follow-up visits.

Conditions

• ACL Injury
• Post Operative Pain

Interventions

Type	Name	Description
DRUG	Adductor Canal Block (ACB) Only	Patients will receive an ACB with lidocaine skin wheal
DRUG	Adductor Canal Block (ACB) + iPACK Block	Patients will receive an ACB with iPACK block

Timeline

• Start date: 2022-08-25
• Primary completion: 2023-07-03
• Completion: 2023-08-14
• First posted: 2022-08-12
• Last updated: 2024-10-16
• Results posted: 2024-07-10

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study